國立高雄大學圖資館 |

Language: English

Back to Search results for [ subject:"Antiviral agents." ]

Advances in Antiviral Drug Design

ScienceDirect (Online service)

Advances in Antiviral Drug Design

Record Type:	Electronic resources : Monograph/item
Title/Author:	Advances in Antiviral Drug Design
Published:	Elsevier Science Ltd2007.
Subject:	Antiviral agents.
Online resource:	http://www.sciencedirect.com/science/book/9780444521736
ISBN:	9780444521736

Advances in Antiviral Drug Design
Advances in Antiviral Drug Design[electronic resource]. - Elsevier Science Ltd2007.

Status presens of antiviral drugs and strategies, Part I: DNA viruses and retroviruses -- Status presens of antiviral drugs and strategies, Part II: RNA viruses (except retroviruses) -- Methylenecyclopropane analogues of nucleosides as anti-herpes agents -- Synthesis and antiviral evaluation of broad spectrum orally active analogs of cidofovir and other acyclic nucleoside phosphonates -- CCR5 antagonists for the treatment of HIV infection and AIDS -- The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses their structure-activity relationship, mechanism and targets of action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.

Mode of access: World Wide Web.

ISBN: 9780444521736

Source: 131812:131918Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

229449
Antiviral agents.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RS431.A66 / A38 2007

Dewey Class. No.: 616.9/1061

Advances in Antiviral Drug Design
LDR:02287cmm 2200337Ia 4500 001 288233
003 OCoLC
005 20110614113927.0
006 m d
007 cr cn|||||||||
008 110628s2007 xx o 000 0 eng d
019 $a 154671015
020 $a 9780444521736
020 $a 0444521739
029 1 $a NZ1 $b 12059960
035 $a (OCoLC)162131368 $z (OCoLC)154671015
035 $a ocn162131368
037 $a 131812:131918 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $c OPELS $d BAKER $d OPELS $d BTCTA $d OPELS
049 $a TEFA
050 1 4 $a RS431.A66 $b A38 2007
082 0 4 $a 616.9/1061 $2 22
245 0 0 $a Advances in Antiviral Drug Design $h [electronic resource].
260 $b Elsevier Science Ltd $c 2007.
505 0 $a Status presens of antiviral drugs and strategies, Part I: DNA viruses and retroviruses -- Status presens of antiviral drugs and strategies, Part II: RNA viruses (except retroviruses) -- Methylenecyclopropane analogues of nucleosides as anti-herpes agents -- Synthesis and antiviral evaluation of broad spectrum orally active analogs of cidofovir and other acyclic nucleoside phosphonates -- CCR5 antagonists for the treatment of HIV infection and AIDS -- The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs).
520 $a Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses their structure-activity relationship, mechanism and targets of action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2007. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on July 25, 2007). $n Access may be restricted to users at subscribing institutions.
650 0 $a Antiviral agents. $3 229449
655 7 $a Electronic books. $2 local. $3 214472
710 2 $a ScienceDirect (Online service) $3 307425
776 1 $c Original $z 9780444521736 $z 0444521739 $w (OCoLC)154671015
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780444521736
938 $a Baker & Taylor $b BKTY $c 130.00 $d 130.00 $i 0444521739 $n 0007202396 $s active
938 $a Baker and Taylor $b BTCP $n BK0007202396
994 $a C0 $b TEF